Isis Pharmaceuticals

Listing Websites about Isis Pharmaceuticals

Filter Type:

ISIS Pharmaceuticals ISIS Stock Price, Company …

(4 days ago) WebIsis Pharmaceuticals, Inc. engages in the development and commercialization of drugs to treat various health conditions, including inflammatory, viral, metabolic and cardiovascular and

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Isis Pharmaceuticals Changes Name to Ionis Pharmaceuticals

(7 days ago) WebCARLSBAD, Calif., Dec. 18, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today announced that the company has changed its name to Ionis …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Home - Isispharma

(Just Now) WebHome - Isispharma. IsisPharma uses cookies to measure the audience of the site and the content offered. IsisPharma also relies on third party services that store cookies in your terminal to enable you to interact on …

Url: Visit Now

Category:  Health Detail Drugs


ISIS PHARMACEUTICALS, INC. : Stock Price US4643301090

(3 days ago) WebISIS PHARMACEUTICALS, INC. Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals Changes Name to Ionis Pharmaceuticals - PR …

(4 days ago) WebIonis Pharmaceuticals. CARLSBAD, Calif., Dec. 18, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today announced that the company has …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ionis Pharmaceuticals - Wikipedia

(1 days ago) WebIonis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has 3 commercially approved medicines: …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Every Moment Matters Ionis

(8 days ago) WebWe Are Transforming the Standard of Care and Pioneering New Markets. As the leader in RNA-targeted therapeutics for more than three decades, Ionis has focused every moment on advancing drug …

Url: Visit Now

Category:  Health Detail Drugs


About Ionis Pharmaceuticals, Inc.

(4 days ago) WebMs. Cadoret-Manier is executive vice president, chief global product strategy and operations officer at Ionis Pharmaceuticals. She is a member of Ionis’ executive leadership team, …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Our Medicines Ionis Pharmaceuticals, Inc.

(2 days ago) WebOur platform technology has served as a springboard for drug discovery and realized hope for patients with unmet needs. Our broad, diverse pipeline has more than 40 first-in-class and/or best-in-class medicines …

Url: Visit Now

Category:  Health Detail Drugs


Ionis Pipeline: Antisense Drugs for a Broad Range of Diseases

(4 days ago) WebChemistry: Generation 2 + LICA. Pelacarsen, also known as IONIS-APO(a)-L Rx , AKCEA-APO(a)-L Rx , and TQJ230, is an investigational antisense medicine designed to reduce …

Url: Visit Now

Category:  Health Detail Drugs


The story - Isispharma

(5 days ago) WebThe story. Since its creation in 1987 by Christian Diehl, a pharmacist based in Bourg-en-Bresse, France, Isispharma Laboratory has focused its research on the natural balance – …

Url: Visit Now

Category:  Health Detail Drugs


What's in a Name? Ask Isis Pharmaceuticals, Which is Becoming Ionis

(1 days ago) WebIsis Pharmaceuticals on Friday announced that it will change its name to Ionis Pharmaceuticals. The company's shares, which now trade on the Nasdaq under …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Isis Pharmaceuticals Begins Huntington's Disease Study - Yahoo!

(3 days ago) WebIsis Pharma currently carries a Zacks Rank #3 (Hold). AMAG Pharmaceuticals, Inc. AMAG is a better-ranked stock in the health care sector carrying …

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Why It’s Not Too Late to Buy Isis Pharmaceuticals Stock

(5 days ago) WebSource: Isis Pharmaceuticals. This impressive pipeline has thus attracted major partners including AstraZeneca , GlaxoSmithKline , and Johnson & Johnson , to …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ISIS-3521. Isis Pharmaceuticals - PubMed

(1 days ago) WebISIS-3521 is a 20-mer antisense phosphorothioate oligonucleotide PKCa expression inhibitor, under development by Isis (formerly in collaboration with Novartis) for the …

Url: Visit Now

Category:  Health Detail Drugs


Isis Pharmaceuticals Announces Adoption of Securities Trading …

(5 days ago) WebIsis Pharmaceuticals, Inc. is exploiting its expertise in RNA to discover and develop novel human therapeutic drugs. The Company has commercialized its first …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ISIS Pharmaceuticals & Chemical Works LinkedIn

(4 days ago) WebISIS Pharmaceuticals & Chemical Works is one of the leading Producers of Allopathic Drugs, Veterinary Medicines, Medical Devices and Herbal/Nutraceutical Products in …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs